captan has been researched along with Cancer of Intestines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bhat, VS; Cohen, SM; Cullen, JM; Gordon, EB; Harris, MA; Proctor, DM; Thompson, CM; Wood, CE | 1 |
Fukushima, S; Hagiwara, A; Ito, N; Ogiso, T; Shibata, M | 1 |
1 review(s) available for captan and Cancer of Intestines
Article | Year |
---|---|
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
Topics: Adverse Outcome Pathways; Animals; Captan; Chromium; Duodenum; Fungicides, Industrial; Humans; Hyperplasia; Intestinal Neoplasms; Mice; Phthalimides; Risk Assessment | 2020 |
1 other study(ies) available for captan and Cancer of Intestines
Article | Year |
---|---|
Carcinogenicity of captafol in B6C3F1 mice.
Topics: Animals; Captan; Carcinogens; Cyclohexenes; Female; Fungicides, Industrial; Heart Neoplasms; Intestinal Neoplasms; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasms, Experimental; Organ Size; Sex Factors; Splenic Neoplasms; Stomach Neoplasms | 1984 |